Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (27) Bähring, Sylvia Dr. (1) Birchmeier, Walter Prof. Dr. (27) Birchmeier-Kohler, Carmen Prof. Dr. (10) Dechend, Ralf Priv. Doz. (5) Falcke, Martin Prof. Dr. (7) Gotthardt, Michael Prof. Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Hübner, Norbert Prof. Dr. (8) Ivics, Zoltan Dr. (3) Izsvak, Zsuzsanna Dr. (4) Jentsch, Thomas Prof. Dr. (23) Kettenmann, Helmut Prof. Dr. (40) Kettritz, Ralph Prof. Dr. (5) Kühn, Ralf Dr. (11) Lee, Young-Ae Prof. Dr. (2) Leutz, Achim Prof. Dr. (10) Lewin, Gary Prof. Dr. (8) Luft, Friedrich Prof. Dr. (74) Morano, Ingo Prof. Dr. (13) Niendorf, Thoralf Prof. Dr. (5) Rajewsky, Klaus Prof. Dr. (8) Rajewsky, Nikolaus Prof. Dr. (1) Sander, Maike Prof. Dr. (5) Scheidereit, Claus Prof. Dr. (5) Schulz-Menger, Jeanette Prof. Dr. (1) Spuler, Simone Prof. (4) Stein, Ulrike Prof. Dr. (9) Walther, Wolfgang Prof. Dr. (10) Wanker, Erich Prof. Dr. (4) Willnow, Thomas Prof. Dr. (11) (-) Blankenstein, Thomas Prof. Dr. (17) (-) Klußmann, Enno PD Dr. (1) (-) Müller, Dominik Prof. Dr. (1) AG Müller/Dechend (ECRC) (1) Ankerproteine und Signaltransduktion (1) Hypertonie-vermittelter Endorganschaden (1) Hypertonie bedingte Endorganschäden (1) Molekulare Immunologie und Gentherapie (17) (-) 1992 (4) 1993 (8) (-) 1994 (6) (-) 1995 (9) 1996 (7) 1997 (12) 1998 (12) 1999 (6) 2000 (15) 2001 (21) 2002 (13) 2003 (18) 2004 (15) 2005 (23) 2006 (11) 2007 (27) 2008 (24) 2009 (17) 2010 (27) 2011 (21) 2012 (21) 2013 (28) 2014 (16) 2015 (21) 2016 (23) 2017 (20) 2018 (17) 2019 (27) 2020 (23) 2021 (25) 2023 (20) 2024 (3) 19 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Klußmann, Enno PD Dr.Müller, Dominik Prof. Dr.199219941995 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein 01. Januar 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein 01. Januar 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling 01. Januar 1995 / Hypertension Effects of human renin in the vasculature of rats transgenic for human angiotensinogen D.N. Mueller K.F. Hilgers J. Bohlender A. Lippoldt J. Wagner W. Fischli D. Ganten J.F.E. Mann F.C. Luft 01. Januar 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein 01. Januar 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu 01. Januar 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein 01. Januar 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein 01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein 01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
01. Januar 1994 / Br J Canc Expression of interleukin 10 in human melanoma S. Krueger-Krasagakes K. Krasagakis C. Garbe E. Schmitt C. Huels T. Blankenstein T. Diamantstein
01. Januar 1995 / Blood Human lymphotoxin has at least equal antitumor activity in comparison to human tumor necrosis factor but is less toxic in mice Z. Qin L.J.H. van Tits W.A. Buurman T. Blankenstein
01. Januar 1995 / J Immunol IL-10 converts mouse lymphoma cells to a CTL-resistant, nk-sensitive phenotype with low but peptide-inducible MHC class I expression F. Salazar-Onfray M. Petersson L. Franksson M. Matsuda T. Blankenstein K. Karre R. Kiessling
01. Januar 1995 / Hypertension Effects of human renin in the vasculature of rats transgenic for human angiotensinogen D.N. Mueller K.F. Hilgers J. Bohlender A. Lippoldt J. Wagner W. Fischli D. Ganten J.F.E. Mann F.C. Luft
01. Januar 1995 / Eur J Immunol Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines S. Cayeux C. Beck A. Aicher B. Doerken T. Blankenstein
01. Januar 1995 / Eur J Cancer European school of oncology position paper - gene therapy for the medical oncologist M. Blaese T. Blankenstein M. Brenner O. Cohenhaguenauer B. Gansbacher B. Sorrentino T. Velu
01. Januar 1995 / Hum Gene Ther The thymidine kinase/ganciclovir-mediated "suicide" effect is highly variable in different tumor cells C. Beck S. Cayeux S. Lupton B. Doerken T. Blankenstein
01. Januar 1995 / Canc Res Tumor growth inhibition mediated by lymphotoxin: evidence of B lymphocyte involvement in the antitumor response Z. Qin T. Blankenstein
01. Januar 1994 / Eur J Cancer Increasing tumour immunogenicity by genetic modification T. Blankenstein
01. Januar 1994 / Canc Res Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL- 10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma- A. Allione M. Consalvo P. Nanni P.L. Lollini F. Cavallo M. Giovarelli M. Forni A. Gulino M.P. Colombo P. Dellabona H. Hock T. Blankenstein F.M. Rosenthal B. Gansbacher M.C. Bosco T. Musso L. Gusella G. Forni